The HeLa cells were discovered in 1951 from Henrietta Lacks. Henrietta Lacks, a poor 30-year old mother, was diagnosed with Epidermiod carcinoma of the cervix stage 1. George Gey, a doctor who worked for Johns Hopkins Hospital in Baltimore, MD, and also someone who was attempting to produce immortal human cells, took a sample of the tumor and later announced to a large television audience that they were “like no other cells." As the cells gained more recognition, Dr. Gey named them "HeLa" cells in honor of Mrs. Lacks, who later died in October of 1951. HeLa cells became an important tool in medicine, but Henrietta remained unknown. Twenty years after Mrs. Lacks' death the family learned of the immortal cells when skeptical scientists investigated the immediate family without consent. For decades after Henrietta's death, generations of the Lacks family never received any of the profits. Struggling without insurance, the family should have received payments from the very beginning.
As a result of the family never being notified of the discovery, the second best choice would be royalty payments. A royalty payment is when one licenses their work or retains legal ownership and someone else duplicates and sells the item. Therefore, in return for granting the license, one receives a royalty -- a continuing payment based on the percentage of the income for the item. The HeLa cells were used for various reasons extending from the development of Polio vaccines to the treatment drugs of Leukemia. In 2001, five Nobel Prizes were awarded just for the research of HeLa cells. Over 50 years of non-stop publicity would be hard to stop and retract to make it seem like it never happened. It would be better for the specific companies who were selling the cells illegally to give a small portion to the family. For example a royalty rate of 5% multiplied by the net sales of $1000 equals a net sales royalty of $50.
Correspondingly, most of the Lacks family does not have health...
Please join StudyMode to read the full document